NCT03013322View on ClinicalTrials.gov

Anticholium® Per Se

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 28, 2015

Primary Completion Date

February 18, 2017

Study Completion Date

February 18, 2017

Conditions
Shock, SepticSepsisPerioperative Period
Interventions
DRUG

Physostigmine

DRUG

Isotonic Saline

Trial Locations (1)

69120

University Hospital Heidelberg, Heidelberg

All Listed Sponsors
lead

University Hospital Heidelberg

OTHER

NCT03013322 - Anticholium® Per Se | Biotech Hunter | Biotech Hunter